Augmentin Dosing for URI and AOM
For acute otitis media (AOM), use high-dose amoxicillin-clavulanate (Augmentin) 90/6.4 mg/kg/day divided twice daily in children, or amoxicillin-clavulanate 2000/125 mg (Augmentin XR) twice daily in adults; for uncomplicated upper respiratory infections (URIs), antibiotics including Augmentin should NOT be used as these are viral infections.
Upper Respiratory Infections (URIs)
Do not prescribe Augmentin or any antibiotic for uncomplicated URIs. Most URIs are viral and resolve without antibiotics 1. The evidence is clear: antibiotics cause more harm than benefit in these cases, with a number needed to harm of 8 versus a number needed to treat of 18 1.
When Antibiotics ARE Indicated (Acute Bacterial Rhinosinusitis)
Reserve antibiotics only when clinical criteria suggest acute bacterial rhinosinusitis (ABRS) 1:
- Persistent symptoms >10 days without improvement
- Severe symptoms: fever >39°C, purulent nasal discharge, or facial pain for ≥3 consecutive days
- "Double sickening": worsening after initial improvement (new fever, headache, or increased nasal discharge after 5 days)
If ABRS is diagnosed, amoxicillin-clavulanate is the preferred first-line agent 1, though some guidelines recommend plain amoxicillin as equally effective.
Acute Otitis Media (AOM) Dosing
Pediatric Dosing (3 months to 12 years)
Standard first-line: High-dose amoxicillin-clavulanate 90/6.4 mg/kg/day divided every 12 hours 2, 3
This formulation (Augmentin ES-600) provides:
- 90 mg/kg/day of amoxicillin component
- 6.4 mg/kg/day of clavulanate component
- Given in 2 divided doses for 10 days
Use high-dose amoxicillin-clavulanate (instead of plain amoxicillin) when 2:
- Child received amoxicillin in previous 30 days
- Concurrent purulent conjunctivitis (otitis-conjunctivitis syndrome)
- Coverage for β-lactamase producers (H. influenzae, M. catarrhalis) is desired
Clinical evidence: This high-dose regimen achieved 98.4% bacteriologic eradication for S. pneumoniae (including 85.7% for penicillin-resistant strains with MIC=4 mcg/mL) and 92.6% for H. influenzae 3. Clinical success rates were 89.1% at 2-4 days post-therapy 3.
Adult Dosing
Amoxicillin-clavulanate 2000/125 mg (Augmentin XR) twice daily 4, 5
This pharmacokinetically enhanced formulation:
- Maintains plasma amoxicillin levels >4 mcg/mL for 49% of dosing interval
- Provides coverage against drug-resistant S. pneumoniae (MICs up to 4 mcg/mL)
- Covers β-lactamase-producing H. influenzae and M. catarrhalis
Alternative Dosing Considerations
Standard-dose amoxicillin-clavulanate (45/6.4 mg/kg/day divided twice daily in children, or 875/125 mg twice daily in adults) can be used for uncomplicated cases without recent antibiotic exposure 6, 7.
Recent evidence shows that once or twice daily dosing is as effective as three times daily for both clinical cure and adverse event rates 7. The twice-daily regimen also improves compliance (82.8% vs 73.3%) 6.
Key Clinical Pitfalls
- Don't use Augmentin for viral URIs: This is the most common error. Most "sinus infections" and "colds" are viral 1
- Don't underdose in AOM: Standard-dose amoxicillin-clavulanate may fail against resistant S. pneumoniae. Use high-dose formulations when resistance is suspected 2, 3
- Recent data supports amoxicillin alone: Despite increasing β-lactamase producers, recent studies show amoxicillin alone has lower failure rates (1.7%) than amoxicillin-clavulanate (11.3%) for AOM 8. However, guidelines still recommend amoxicillin-clavulanate for specific risk factors 2
- Watch for diarrhea: Protocol-defined diarrhea occurs in 11-13% of children on high-dose formulations 3, though this is comparable to standard doses
Treatment Duration
10 days is standard for AOM in children 2, 3. Shorter courses may be considered in older children with mild disease, but this is not well-established for Augmentin specifically.